Marijuana Smoke Crippled the Lung Cells That Kill Bacteria in Rats ↗
Marijuana smoke reduced lung immune cell bacteria-killing from 78% to 11% in a dose-dependent pattern. The toxic component was in the gas phase, not THC.
Explore published research on respiratory, including study methods and limitations.
Marijuana smoke reduced lung immune cell bacteria-killing from 78% to 11% in a dose-dependent pattern. The toxic component was in the gas phase, not THC.
A 1978 medical review identified cannabis as promising for glaucoma and asthma but flagged cardiovascular risks during exercise and preliminary concerns about lung and immune effects.
A major 1986 pharmacological review found cannabis's greatest health concern was its impact on youth development, while finding no proven brain damage and limited physical dependence in adults.
A cancer patient developed a dangerous lung fungal infection while using illicitly obtained marijuana during chemotherapy, highlighting contamination risks for immunocompromised users.
Daily marijuana smoking produced tobacco-like respiratory symptoms, but COPD would likely require 4-5 joints daily for 30+ years. Cancer risk was documented in case reports but not quantified.
Comprehensive review finding solid evidence for cannabinoids in nausea and appetite, emerging evidence for pain and spasticity, and weak evidence for glaucoma and asthma, while advocating for non-smoked delivery methods.
Study finding marijuana smoke impaired lung macrophage bacterial killing through nitric oxide suppression, unlike tobacco smoke, though the impairment was reversible with immune stimulation.
Review found marijuana smoking causes airway inflammation, chronic cough, and precancerous cell changes, but epidemiological evidence for COPD and lung cancer remained limited and inconsistent.
Pooled analysis of 430 lung cancer cases from North Africa found cannabis smoking associated with 2.4x higher risk after adjusting for tobacco, with combined tobacco+cannabis use carrying an 18.2x risk.
Systematic comparison found marijuana smoke contained up to 20x more ammonia and 3-5x more HCN than tobacco, but lower levels of some carcinogenic PAHs in mainstream smoke.
In a study of 636 NPC patients and 615 controls across North Africa, marijuana smoking independently elevated nasopharyngeal cancer risk, separate from cigarette smoking effects.
Review found emerging evidence linking habitual cannabis smoking to COPD, pneumothorax, respiratory infections, and potentially lung cancer.
Comprehensive review found recreational cannabis adverse effects were generally minor, with overall harms appearing less serious than alcohol, though vulnerable individuals faced greater risks.
Cannabis smoking consistently caused airway inflammation and bronchitis but surprisingly little evidence supported COPD or emphysema risk, and lung cancer evidence was inconclusive.
Tiny pilot found cannabis extract may change how COPD patients perceive breathlessness without affecting standard measurements.
A single dose of CBD reduced lung inflammation across multiple markers in mice, working through the adenosine A2A receptor pathway.
Review found regular marijuana smoking causes bronchitis symptoms and airway inflammation, while occasional use does not increase COPD risk and the cancer link remains unproven.
Review found marijuana smoke causes cough and sputum similar to tobacco but does not appear to cause COPD, with mixed and unclear evidence on cancer risk.
29 burn patients admitted to a Colorado burn center from homemade butane hash oil extraction, with cases increasing sharply after marijuana liberalization.
Large U.S. survey found up to 20 joint-years of marijuana use did not impair lung function. Heavier use altered airflow patterns, but differently from tobacco-related lung disease.
Scottish study of 500 smokers found adding cannabis to tobacco was associated with worse respiratory symptoms and a small increase in COPD rates beyond tobacco alone.
Survey of 2,002 college students found 17% allowed marijuana smoking in their homes versus 14.5% for cigarettes, with different social factors predicting each.
Vaping cannabis reduces toxic smoke exposure, but the lung health advantage over smoking may be smaller than the benefit e-cigarettes offer over tobacco.
Systematic review of 48 studies found smoked marijuana is associated with lung cancer risk, emphysema, COPD, and respiratory symptoms including wheezing, cough, and phlegm.
Literature review finds cannabis smoking causes bronchitis symptoms but, unlike tobacco, is associated with increased lung capacity, possibly due to cannabis's bronchodilator and anti-inflammatory effects.
Just one minute of marijuana secondhand smoke impaired blood vessel function for 90+ minutes, longer than tobacco smoke, and the effect was caused by combustion products, not cannabinoids.
National survey data shows exclusive marijuana smokers had significantly elevated urinary levels of carcinogenic combustion by-products (PAHs, VOC metabolites) compared to non-users.
Review finds cannabis smoke causes bronchitis, may lead to pneumonia and airway obstruction, and poses a potential but inconclusive lung cancer risk with long-term heavy use.
Cannabis use disorder diagnoses in US hospitals nearly tripled from 2002-2011, with psychiatric disorders as the top comorbidity and patients trending older and sicker.
Pulmonology review showing marijuana smoke shares many harmful combustion products with tobacco smoke, affecting the respiratory tract of the estimated 2.5-5% of people who use cannabis globally.
First systematic comparison showing marijuana smoke caused earlier and more severe lung damage than tobacco in mice over 4 months, with effects independent of CB1 cannabinoid receptors.
Systematic review of 15 studies finding secondhand marijuana smoke causes detectable cannabinoid metabolites, psychoactive effects, and eye irritation, with THC content and ventilation as key factors.
Systematic review of 15 studies finding THC does not improve aerobic performance or strength, inhibits exercise-induced asthma, and triggered angina at lower workloads in all cardiac-vulnerable subjects.
Survey of 6,089 Hawaiian teens found e-cigarette use independently associated with asthma (aOR 1.48), while marijuana and cigarette use were not significant after controlling for e-cigarettes.
National survey found regular marijuana smoking associated with 34% higher odds of poor self-rated health even without tobacco, rising to nearly double with concurrent tobacco use.
Study of 43 hospitalized Colorado toddlers found 16% had detectable marijuana metabolites, with higher rates in non-white children and those exposed to tobacco smoke.
Randomized trial of 16 adults with severe COPD found vaporized cannabis had no meaningful effect on breathlessness, exercise capacity, or lung function.
Interviews with 30 teens found marijuana blunt use frequently led to standalone cigarillo tobacco smoking, with group sharing and substitution driving co-use.
Review found smoking cannabis has not been proven to cause lung cancer, while noting emerging therapeutic potential for chemo-related nausea and cancer pain. Better studies needed.
Lab study found cannabis smoke triggered DNA damage, impaired immune defenses, and caused inflammatory responses in human airway cells strikingly similar to tobacco smoke.
A 25-year-old developed delayed brain hemorrhage days after synthetic cannabinoid use, despite an initially normal brain CT, highlighting the risk of late intracranial complications.
High-sensitivity testing found 25% of urban teens positive for THC, far more than standard tests detected. Cigarette smokers had 13x the odds of marijuana use.
A review found cannabis smoke can trigger asthma attacks and allergic reactions, with users showing more symptoms and medical visits, making cannabis an underrecognized respiratory disease trigger.
A survey found 7.5% of Ontario apartment residents were involuntarily exposed to cannabis smoke from neighbors, similar to tobacco smoke exposure (6.6%), with lower-income residents most affected.
Utah EVALI investigation found 92% of patients used THC vaping products, with vitamin E acetate detected in 89% of tested THC cartridges.
Review finds cannabis smoking produces similar combustion chemicals and cardiovascular risks as tobacco, including heart attacks, arrhythmias, and strokes, potentially at younger ages.
Systematic review links cannabis smoking to darkened vocal folds, respiratory symptoms, and lung function changes in heavy users, with vaporizing offering symptom reduction.
The 2019 EVALI outbreak caused 805 lung injury cases and 12 deaths. Over three-quarters of patients with substance data reported using THC vaping products.
Indoor cannabis smoking was associated with higher air particle levels and a non-significant trend toward worse child health outcomes in homes where tobacco was already smoked.
THC was detected on room surfaces after cannabis vaping at levels up to 4,882 ng/m2, demonstrating third-hand cannabis exposure potential.
Study of 1,285 adults aged 40+ found heavy marijuana smoking more than doubled COPD risk and accelerated lung decline beyond tobacco alone.
Review finds cannabis smokers show similar airway symptoms as tobacco smokers, plus unique immune cell deficits, but COPD progression from cannabis alone remains unclear.
Analysis of nearly 9,000 cannabis users found elevated risk of asthma, COPD, and pneumonia even among those without tobacco use disorder.
Case report of an adolescent with severe lung injury from vaping cannabis oil, highlighting emerging respiratory risks.
Review of cannabis vaping lung injury cases found acute respiratory failure as a serious complication, identifying key cannabis oil ingredients as potential causes.
Survey of 1,030 NYC subsidized housing residents found 67% experienced secondhand marijuana smoke in their homes, exceeding cigarette smoke exposure.
A CDC/NEJM study found vitamin E acetate in 94% of EVALI patients' lung fluid across 16 states, with 94% of patients linked to THC vaping, identifying the primary toxicant behind the 2019 vaping lung injury outbreak.
A systematic review found 12 cases of acute eosinophilic pneumonia from marijuana, vaping, and other non-cigarette products. Most patients were young, many needed ICU care, but all recovered with corticosteroid treatment.
A previously healthy 28-year-old developed acute respiratory failure from lipoid pneumonia 2 weeks after using a street-bought THC vape cartridge, confirmed by BAL staining and treated with IV corticosteroids.
Review of the 2019 EVALI outbreak links cases primarily to vaping unlicensed THC products containing vitamin E acetate, with about 2% mortality and predominant presentation in young men.
Review found cannabis users may need more sedation and pain medication during surgery, with THC vaping adding respiratory risks from potential lung injury.
Mouse study found CBD reversed ARDS symptoms and increased apelin expression in lungs and blood, revealing a new CBD mechanism for respiratory inflammation.
Survey of 4,088 adults found 27.4% had recent marijuana secondhand smoke exposure in public, while 81% opposed public marijuana smoking and 52.4% perceived it as harmful.
Cannabis vaping doubled among U.S. adults from 2017 to 2019, tripling among 18-24 year olds. While not linked to respiratory symptoms, cannabis vaping was strongly associated with heavy drinking and other high-risk behaviors.
Validated mouse model showed cannabis smoke increased lung macrophages without neutrophil infiltration, plus elevated immune mediators, in both male and female mice.
Review found cannabis smoking causes bronchitis and increases airway resistance but does not clearly cause COPD, emphysema, or lung cancer, a pattern distinctly different from tobacco.
Analysis of 6 million COPD hospitalizations found cannabis users had 37.6% lower odds of in-hospital death and 11.8% lower odds of pneumonia compared to non-users.
A national longitudinal study of 7,821 US adolescents found that existing substance use, particularly other marijuana products and e-cigarettes, strongly predicted starting to vape marijuana.
A study found chronic cannabis smokers had elevated oral Actinomyces meyeri bacteria. When this bacterium was fed to mice for six months, it decreased activity and increased amyloid-beta production in their brains.
A 48-year-old man with long-term tobacco and cannabis smoking developed vanishing lung syndrome, a rare form of severe emphysema, highlighting potential additive respiratory risks from dual use.
Survey of 382 NYC families found 31% reported marijuana smoke entering their homes while with their children, with public housing residents 3.45 times more likely to be exposed.
Study of 53 young children in NYC found 20.8% had detectable marijuana metabolites in their urine, with rates nearly tripling in housing where smoking was allowed.
A global survey of 107,272 people found cannabis was more commonly smoked indoors than tobacco, with 78.8% of cannabis-only users smoking at home vs. 67.9% of tobacco-only users.
Cannabis vaporizers reduce respiratory toxins and symptoms compared to smoking but are not risk-free, especially for new users who face cognitive impairment and dependence risks.
Large survey found about 1 in 5 residents reported secondhand cannabis smoke at home, with higher rates in multi-unit housing across both legal and illegal jurisdictions.
First case of pneumorrhachis (spinal air leak) linked to cannabinoid hyperemesis syndrome, caused by severe, repeated vomiting.
Among 3.3 million cannabis hospitalizations, pulmonary circulation disorders increased 200% over 7 years, with patients facing 2x the in-hospital mortality risk.
Children of caregivers who smoked marijuana had 26% more viral respiratory infections per year compared to unexposed children in a survey of 1,500 families.
Marijuana causes bronchitis but the evidence suggests it does not cause COPD and probably does not cause lung cancer, a distinctly different pattern from tobacco.
Among 1,472 bladder cancer patients, marijuana use (25%) was not linked to recurrence, while tobacco smoking duration strongly predicted cancer return.
Population survey found adults using both marijuana and e-cigarettes were 12 times more likely to be under 30 and had elevated rates of poor mental health, respiratory conditions, and cigarette smoking.
Study measured fine particulate matter from secondhand cannabis bong smoke in a home, showing bystanders face meaningful PM2.5 exposure during social smoking sessions.
Controlled experiments found one marijuana joint produced 4.4 times more fine particulate matter than a tobacco cigarette in a home, with smoke detectable in all 9 rooms.
Review found smoking marijuana causes chronic bronchitis symptoms but no significant FEV1 decline, and most studies have not linked it to lung cancer.
Ontario population study of 35,000+ people found cannabis use was not linked to respiratory ER visits but was associated with 22% more all-cause hospitalizations.
NYC survey found 30.7% of families experienced marijuana smoke incursions during the pandemic, with families in subsidized housing facing nearly 7 times the odds and their children having 3 times the asthma rate.
A 34-year-old man developed life-threatening lung bleeding (diffuse alveolar hemorrhage) after smoking K2/Spice synthetic cannabis, successfully treated with IV steroids.
JAMA study found 44% of US adults now view daily cannabis smoking as safer than tobacco, up from 37% in 2017, a perception that diverges from existing evidence on smoke risks.
Pilot study found secondhand marijuana smoke PM2.5 levels up to 149 ug/m3 at golf courses and public parks, with over 20% of golf course visits encountering exposure.
Prenatal cannabinoid exposure disrupted breathing regulation in rat offspring sex-specifically: males had altered CO2/O2 responses while females had increased apnea with reduced brainstem serotonin neurons.
Review found inhaled cannabis dampens lung immune function, potentially reducing inflammation but also impairing pathogen defense, with major knowledge gaps remaining.
Lab study showed CBD oil and vitamin E acetate in vaping aerosols accumulated on and inside human airway cells, causing dramatic cell death and metabolic stress.
Scoping review of 2,589 articles found only 22 studying cannabis in ICU settings, revealing major research gaps and inconsistent findings on outcomes.
Among 167,095 ICU pneumonia patients, alcohol misuse increased mortality while cannabis misuse showed no independent association after statistical adjustment.
Systematic review finds marijuana smoking linked to airway inflammation, chronic bronchitis, and possible associations with pneumonia and emphysema.
Population study of 150,634 California teens found e-cigarettes, cigarettes, and cannabis each independently associated with asthma, with additive combined effects.
Case report documents spontaneous pneumothorax from cannabis-induced bullous lung disease in a young adult, highlighting an underrecognized smoking complication.
Smoked marijuana causes bronchitis symptoms and airway changes, but hasn't been linked to progressive lung function decline or clearly increased lung cancer risk — a paradox given its similarity to tobacco smoke.
Thai national analysis found geographic overlap between cannabis and TB hospitalizations, with a non-significant 48% higher TB hazard in those with prior cannabis admission, leaving the causal question open.
Thai case-control study found sharing cannabis bongs associated with 4.2x higher TB odds, with a population-attributable fraction (12.2%) nearly equal to tobacco smoking (12.6%), suggesting device sharing is the key risk behavior.
Survey of 5,410 Oklahoma adults found 42% had recent secondhand cannabis smoke exposure, with higher respiratory symptoms especially among those who also used cannabis, and disproportionate exposure among young, minority, and lower-SES populations.
Systematic review finds smoking cannabis carries the most cardiovascular and respiratory risks, vaping may reduce respiratory harm, and edibles/dabbing are poorly studied.
California survey of ~159,000 students found secondhand marijuana smoke exposure nearly as common as tobacco secondhand smoke, with higher rates among students with asthma.
National survey of 8,033 young adults found cannabis vaping associated with wheezing and cough at rates comparable to nicotine vaping — dual vaping had the worst respiratory symptoms.
21-country survey of 28,154 drug users found higher perceived harm from secondhand cannabis smoke was associated with 70% greater odds of not smoking cannabis at home.
US survey of 21,381 adults found perceiving secondhand cannabis smoke as "extremely harmful" was associated with 6x higher odds of banning cannabis smoking in the home.
Global Drug Survey of 64,000 cannabis users found about 64% smoked at home, with daily home smoking in roughly 25-28%, raising concerns about residential secondhand smoke exposure.
Despite fewer toxicants in vapor, cannabis vaping triggered the same inflammatory, cancer, and stress gene pathways in lung cells as smoking — questioning the harm reduction narrative at the molecular level.
Survey of 110 Canadian CF patients: 43% use cannabis, 85% for medical reasons (stress, insomnia, anxiety). Most rate it effective. Legalization reduced stigma.
Survey of 302 cannabis users found few perceived differences between vaping and smoking risks, though younger users and women saw more mental health benefits from vaping.
Legal Canadian cannabis vape products contained metal particles from device components in both liquid and inhaled aerosol.
Cannabis smoking clearly causes bronchitis symptoms and impairs lung immune function, but decades of research have failed to establish a consistent link to lung cancer despite the presence of known carcinogens in the smoke.
Lab analysis of 14 hemp cigarette brands found metal levels similar to tobacco, with lower cadmium but several brands exceeding state limits for other metals.
Difference-in-differences analysis found states with cannabis dispensaries and legal recreational cannabis had 14-20% more asthma hospitalizations than comparison states.
Vaped THC promoted Candida albicans growth, biofilm formation, and virulence gene expression in a dose-dependent manner in vitro.
A review found unregulated cannabinoid vaping products contain high concentrations and produce potentially toxic heating byproducts called quinones that may damage lung tissue.
Meta-analysis of 8 studies found cannabis users had 31% higher odds of asthma diagnosis than non-users, with consistent results across sensitivity analyses.
CB1 receptor blocker caused 27% weight loss in obese mice and improved airway function, identifying the endocannabinoid system as a link between obesity and asthma.
Review finds cannabis concentrate vaping produces significant toxic byproducts and some products contain hazardous additives, as research lags far behind market growth.
An Ontario study of 11.6 million people found that individuals hospitalized for cannabis use disorder were nearly 3 times more likely to die within 5 years, with especially high risks for suicide and trauma.
Multi-state surveillance identified 30 cases of work-related asthma in cannabis workers, mostly from dust exposure in indoor cultivation, including two fatalities.
Mouse study found adolescent cannabinoid exposure primed lungs for worse bacterial infections in adulthood, amplified when combined with alcohol.
Animal study found prenatal cannabinoid exposure impaired breathing reflexes and cardiovascular responses in juvenile rats, with sex-specific effects.
Prospective study of 150 young lung cancer patients found 39% smoked both cannabis and tobacco, with dual smokers showing more aggressive cancers and emphysema than tobacco-only smokers.
Analysis of 379,049 adults found daily inhaled cannabis associated with 44% higher asthma odds and 27% higher COPD odds, persisting after tobacco adjustment.
Primate study found prenatal edible THC exposure reduced infant lung volumes and altered lung gene expression through epigenetic changes at 6 months of age.
National analysis of 552,160 asthma hospitalizations found cannabis use disorder associated with 2.4x higher mortality, 35% more severe exacerbations, and higher hospital charges.
A survey of 3,200 parents found children exposed to secondhand cannabis smoke had 2.1x higher wheezing risk and 1.8x higher nighttime cough risk.
Cannabis smoke plus seed oil diet weakened heart function, suppressed anti-inflammatory mediators, and increased immune activation in mice.
Cannabis vapor activated cancer, inflammation, and oxidative stress genes in human lung cells—without triggering DNA damage, suggesting a unique harm mechanism.
Vaping cannabis reduces some combustion harms but produces similar cardiovascular effects to smoking and introduces its own lung risks—not a safe alternative.
First study of COPD patients finds combined cannabis+tobacco smoking produces higher lung volumes and 4x more bullous emphysema than tobacco alone, suggesting distinct cannabis lung damage.
Multi-modal Canadian study found heavy cannabis smokers had worse lung function, airway structural changes, and overproduction of mucus-related genes in airway cells.
Co-use of methamphetamine and cannabis linked to higher intubation rates and more severe asthma attacks among hospitalized patients.
Survey of 9,100 adults found 45% of cigarette smokers in high-tobacco states also use cannabis, with co-use most common among young, male, and disabled individuals.
CARDIA cohort, 5,115 people, 20 years: cannabis smoking showed a nonlinear pattern — slight lung function improvement at low exposure, leveling off at moderate, trend toward decline only at very high exposure. The opposite of tobacco's linear harm.